Filing Details
- Accession Number:
- 0001140361-15-013272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-26 18:53:43
- Reporting Period:
- 2015-03-25
- Filing Date:
- 2015-03-26
- Accepted Time:
- 2015-03-26 18:53:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 913077 | Affymetrix Inc | AFFX | Laboratory Analytical Instruments (3826) | 770319159 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1485088 | J. Andrew Last | C/O Affymetrix, Inc. 3420 Central Expressway Santa Clara CA 95051 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-25 | 90,000 | $5.29 | 260,112 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-25 | 20,000 | $4.22 | 280,112 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-25 | 110,000 | $12.79 | 170,112 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2015-03-25 | 90,000 | $0.00 | 90,000 | $5.29 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2015-03-25 | 20,000 | $0.00 | 20,000 | $4.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-12-17 | No | 4 | M | Direct | |
| 50,000 | 2017-08-19 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a 10b5-1 Trading Plan.
- These sales were executed in multiple trades at prices ranging from $12.685 to $12.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Stock option became exercisable in equal annual installments over four years from the grant date of December 17, 2009.
- Stock option became exercisable in equal annual installments over four years from the grant date of August 19, 2010.
Billionaire Hedge Funds
